As part of our virtual Partners & Platforms Seminars series, the UK DRI is delighted to welcome Professor Franklin Aigbirhio.
"Development and Application of Molecular Imaging Methods and Infrastructure for Dementia Research"
A central technology used by the Dementia Platform UK (DPUK) for its experimental medicine programmes is molecular imaging based on the application magnetic resonance imaging and positron emission tomography methods. Describing how the DPUK uses this technology, Professor Aigbirhio will cover the following topics:
- The development and application of positron emission tomography methods to image and delineate the various pathologic components of neurodegenerative disorders e.g. tau, beta-amyloid, neuroinflammation etc.
- The infrastructure established by DPUK to fully utilize these imaging techniques across the network
- Examples of on-going imaging studies within the network
Tuesday 28 July 2020, 12:00 - 13:00 BST
This event is open to UK DRI researchers and support staff only. Registration and associated Zoom links will be distributed via Centre Manager emails nearer the time of the event.
-
Professor Franklin I Aigbirhio MA DPhil FRSC
Dementia Platform UK Imaging Network & University of Cambridge
Franklin Aigbirhio obtained a BSc(Hons) in chemistry from the University of East Anglia (UK) followed by a DPhil from the University Sussex (UK). He entered the research field of radiochemistry and biomedical imaging on joining the MRC Cyclotron Unit at Imperial College London in 1991. He then joined the Wolfson Brain Imaging Centre (WBIC), University of Cambridge in 1997 as a founding staff member, help establish its PET programmes and progressed to Co-Director of the centre in 2016. Presently as Professor of Molecular Imaging Chemistry he manages a lab undertaking research programmes in developing novel PET imaging probes and methods and their application to preclinical and clinical research in neuroscience. He is the lead for the Dementia-Platform UK Imaging Network, a Senior Research Fellow at Magdalene College Cambridge and a Director of the International Society of Radiopharmaceutical Sciences.
